| Approved Symbol |
Approved Name |
Source |
Evidence[PMID] |
| TBX1 |
T-box 1 |
Mapped by CNV |
IMP[14585638]
|
| TXNRD2 |
thioredoxin reductase 2 |
Mapped by CNV; Mapped by LD-proxy; Mapped by literature SNP |
|
| FGF19 |
fibroblast growth factor 19 |
Mapped by significant region |
|
| PLCE1 |
phospholipase C, epsilon 1 |
Mapped by PBA pathway |
TAS[11022047]
|
| CRKL |
v-crk sarcoma virus CT10 oncogene homolog (avian)-like |
Mapped by CNV |
|
| FOXL1 |
forkhead box L1 |
Mapped by significant region |
|
| ERBB2 |
v-erb-b2 erythroblastic leukemia viral oncogene homolog 2, neuro/glioblastoma derived oncogene homolog (avian) |
Mapped by LD-proxy |
TAS[15504738]
|
| GJA1 |
gap junction protein, alpha 1, 43kDa |
Mapped by significant region |
|
| ADAM19 |
ADAM metallopeptidase domain 19 |
Mapped by significant region |
|
| NCOA6 |
nuclear receptor coactivator 6 |
Mapped by PBA pathway |
|
| NFATC4 |
nuclear factor of activated T-cells, cytoplasmic, calcineurin-dependent 4 |
Mapped by significant region |
|
| TCF25 |
transcription factor 25 (basic helix-loop-helix) |
Mapped by significant region |
NAS[16574069]
|
| MED12 |
mediator complex subunit 12 |
Mapped by PBA pathway |
|
| ATM |
ataxia telangiectasia mutated |
Mapped by CNV; Mapped by significant region |
|
| TGFBR1 |
transforming growth factor, beta receptor 1 |
Mapped by significant region |
|
| OXCT1 |
3-oxoacid CoA transferase 1 |
Mapped by significant region |
|
| FOXF1 |
forkhead box F1 |
Mapped by significant region |
IMP[19500772]
|
| EDNRA |
endothelin receptor type A |
Mapped by PBA pathway |
|
| FOXC2 |
forkhead box C2 (MFH-1, mesenchyme forkhead 1) |
Mapped by significant region |
|